NDC 0078-1217 – Pluvicto

Lutetium Lu-177 Vipivotide Tetraxetan 27 mCi/mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC0078-1217

Product details

Brand name
Pluvicto
Generic name
lutetium Lu 177 vipivotide tetraxetan
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
NDA · NDA215833
Marketed since
March 23, 2022
Listing expires
December 31, 2027
Pharmacologic class
Radioligand Therapeutic Agent

Active ingredients

Uses, dosage, side effects and warnings for Pluvicto →

Package NDC codes (1)

Package NDCDescriptionSince
0078-1217-611 VIAL, GLASS in 1 PACKAGE (0078-1217-61) / 7.5 mL in 1 VIAL, GLASSJan 15, 2026